Skin-Resident Effector Memory CD8+CD28– T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis

Journal of Investigative Dermatology

Volumn 137, Issue 5, 2017, Pages 1042-1050

  Li, Gang ^a   Larregina, Adriana T ^a   Domsic, Robyn T ^a   Stolz, Donna B ^a   Medsger, Thomas A ^a   Lafyatis, Robert ^a   Fuschiotti, Patrizia ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GAMMA INTERFERON; INTERLEUKIN 13; CD28 ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLYSIS; CYTOTOXICITY; EFFECTOR CELL; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; SKIN FIBROBLAST; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE SUBPOPULATION; CASE CONTROL STUDY; FIBROSIS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SKIN; YOUNG ADULT;

ADULT; AGED; ANTIGENS, CD28; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; COLLAGEN; FEMALE; FIBROSIS; HUMANS; INTERLEUKIN-13; MALE; MIDDLE AGED; PHENOTYPE; SCLERODERMA, SYSTEMIC; SKIN; YOUNG ADULT;

EID: 85017563423     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.11.037     Document Type: Article

References (48)

1. Abedin, S., Michel, J.J., Lemster, B., Vallejo, A.N., Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Exp Gerontol 40 (2005), 537–548.
2. Aktas, E., Kucuksezer, U.C., Bilgic, S., Erten, G., Deniz, G., Relationship between CD107a expression and cytotoxic activity. Cell Immunol 254 (2009), 149–154.
3. Aliprantis, A.O., Wang, J., Fathman, J.W., Lemaire, R., Dorfman, D.M., Lafyatis, R., et al. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci USA 104 (2007), 2827–2830.
4. Appay, V., Dunbar, P.R., Callan, M., Klenerman, P., Gillespie, G.M., Papagno, L., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8 (2002), 379–385.
5. Betts, M.R., Brenchley, J.M., Price, D.A., De Rosa, S.C., Douek, D.C., Roederer, M., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 (2003), 65–78.
6. Casciola-Rosen, L., Andrade, F., Ulanet, D., Wong, W.B., Rosen, A., Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 190 (1999), 815–826.
7. Clark, R.A., Resident memory T cells in human health and disease. Sci Transl Med, 7, 2015, 269rv1.
8. Clark, R.A., Chong, B.F., Mirchandani, N., Yamanaka, K., Murphy, G.F., Dowgiert, R.K., et al. A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 126 (2006), 1059–1070.
9. Clements, P.J., Lachenbruch, P.A., Seibold, J.R., Zee, B., Steen, V.D., Brennan, P., et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20 (1993), 1892–1896.
10. Dvergsten, J.A., Mueller, R.G., Griffin, P., Abedin, S., Pishko, A., Michel, J.J., et al. Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis. Arthritis Rheum 65 (2013), 2201–2210.
11. Fann, M., Chiu, W.K., Wood, W.H. 3rd, Levine, B.L., Becker, K.G., Weng, N.P., Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging. Immunol Rev 205 (2005), 190–206.
12. Fenoglio, D., Battaglia, F., Parodi, A., Stringara, S., Negrini, S., Panico, N., et al. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clin Immunol 139 (2011), 249–257.
13. Fuschiotti, P., CD8(+) T cells in systemic sclerosis. Immunol Res 50 (2011), 188–194.
14. Fuschiotti, P., Larregina, A.T., Ho, J., Feghali-Bostwick, C., Medsger, T.A. Jr., Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum 65 (2013), 236–246.
15. Fuschiotti, P., Medsger, T.A. Jr., Morel, P.A., Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum 60 (2009), 1119–1128.
16. Gabrielli, A., Avvedimento, E.V., Krieg, T., Scleroderma. N Engl J Med 360 (2009), 1989–2003.
17. Geskin, L.J., Viragova, S., Stolz, D.B., Fuschiotti, P., Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Blood 125 (2015), 2798–2805.
18. Goldberg, J.E., Sherwood, S.W., Clayberger, C., A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry. J Immunol Methods 224 (1999), 1–9.
19. Greenblatt, M.B., Sargent, J.L., Farina, G., Tsang, K., Lafyatis, R., Glimcher, L.H., et al. Interspecies Comparison of Human and Murine Scleroderma Reveals IL-13 and CCL2 as Disease Subset-Specific Targets. Am J Pathol 180 (2012), 1080–1094.
20. Hamann, D., Baars, P.A., Rep, M.H., Hooibrink, B., Kerkhof-Garde, S.R., Klein, M.R., et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 186 (1997), 1407–1418.
21. Hasegawa, M., Fujimoto, M., Kikuchi, K., Takehara, K., Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24 (1997), 328–332.
22. Kahaleh, M.B., Fan, P.S., Mechanism of serum-mediated endothelial injury in scleroderma: identification of a granular enzyme in scleroderma skin and sera. Clin Immunol Immunopathol 83 (1997), 32–40.
23. LeRoy, E.C., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T.A. Jr., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 (1988), 202–205.
24. LeRoy, E.C., Medsger, T.A. Jr., Criteria for the classification of early systemic sclerosis. J Rheumatol 28 (2001), 1573–1576.
25. Lo, D.J., Weaver, T.A., Stempora, L., Mehta, A.K., Ford, M.L., Larsen, C.P., et al. Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 11 (2011), 22–33.
26. Masi, A., Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23 (1980), 581–590.
27. Matloubian, M., Lo, C.G., Cinamon, G., Lesneski, M.J., Xu, Y., Brinkmann, V., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004), 355–360.
28. Medsger, T.A. Jr., Bombardieri, S., Czirjak, L., Scorza, R., Della Rossa, A., Bencivelli, W., Assessment of disease severity and prognosis. Clin Exp Rheumatol 21 (2003), S42–S46.
29. Medsger, T.A. Jr., Ivanco, D.E., Kardava, L., Morel, P.A., Lucas, M.R., Fuschiotti, P., GATA-3 upregulation in CD8+ T cells is a biomarker of immune dysfunction in systemic sclerosis, resulting in excess IL-13 production. Arthritis Rheum 63 (2011), 1738–1747.
30. Mikulkova, Z., Praksova, P., Stourac, P., Bednarik, J., Strajtova, L., Pacasova, R., et al. Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis. Cell Immunol 262 (2010), 75–79.
31. Rice, L.M., Ziemek, J., Stratton, E.A., McLaughlin, S.R., Padilla, C.M., Mathes, A.L., et al. A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheumatol 67 (2015), 3004–3015.
32. Schaerli, P., Ebert, L., Willimann, K., Blaser, A., Roos, R.S., Loetscher, P., et al. A skin-selective homing mechanism for human immune surveillance T cells. J Exp Med 199 (2004), 1265–1275.
33. Schirmer, M., Goldberger, C., Wurzner, R., Duftner, C., Pfeiffer, K.P., Clausen, J., et al. Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res 4 (2002), 71–76.
34. Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH Image to ImageJ: 25 years of image analysis. Nature Methods 9 (2012), 671–675.
35. Shiow, L.R., Rosen, D.B., Brdickova, N., Xu, Y., An, J., Lanier, L.L., et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440 (2006), 540–544.
36. Skon, C.N., Lee, J.Y., Anderson, K.G., Masopust, D., Hogquist, K.A., Jameson, S.C., Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat Immunol 14 (2013), 1285–1293.
37. Strioga, M., Pasukoniene, V., Characiejus, D., CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology 134 (2011), 17–32.
38. Sun, Z., Zhong, W., Lu, X., Shi, B., Zhu, Y., Chen, L., et al. Association of Graves’ disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. J Clin Immunol 28 (2008), 464–472.
39. Takata, H., Takiguchi, M., Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol 177 (2006), 4330–4340.
40. Thome, J.J., Farber, D.L., Emerging concepts in tissue-resident T cells: lessons from humans. Trends Immunol 36 (2015), 428–435.
41. Tulunay, A., Yavuz, S., Direskeneli, H., Eksioglu-Demiralp, E., CD8+CD28-, suppressive T cells in systemic lupus erythematosus. Lupus 17 (2008), 630–637.
42. Valenzuela, H.F., Effros, R.B., Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin Immunol 105 (2002), 117–125.
43. Varga, J., Abraham, D., Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117 (2007), 557–567.
44. Watanabe, R., Gehad, A., Yang, C., Scott, L.L., Teague, J.E., Schlapbach, C., et al. Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci Transl Med, 7, 2015, 279ra39.
45. Weng, N.P., Akbar, A.N., Goronzy, J., CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 30 (2009), 306–312.
46. Wolint, P., Betts, M.R., Koup, R.A., Oxenius, A., Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J Exp Med 199 (2004), 925–936.
47. Wynn, T.A., Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4 (2004), 583–594.
48. Ziegler, S.F., Ramsdell, F., Alderson, M.R., The activation antigen CD69. Stem cells 12 (1994), 456–465.